BIOMARKER:

MAP2K1 P124Q

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

MAP2K1 P124Q	Melanoma	MAP2K1 P124Q	Melanoma	trametinib Resistant: C3 – Early Trials trametinib Resistant : C3	trametinib Resistant: C3 – Early Trials trametinib Resistant : C3
MAP2K1 P124Q	Melanoma	MAP2K1 P124Q	Melanoma	dabrafenib Sensitive: C3 – Early Trials dabrafenib Sensitive : C3	dabrafenib Sensitive: C3 – Early Trials dabrafenib Sensitive : C3
MAP2K1 P124Q	Melanoma	MAP2K1 P124Q	Melanoma	VTX-11e Sensitive: D – Preclinical VTX-11e Sensitive : D	VTX-11e Sensitive: D – Preclinical VTX-11e Sensitive : D

Associations